cbdMD, Inc. YCBD announced the closing of its underwritten public offering of 1.35 million shares of its common stock at a public offering price of $2.10 per share. Gross proceeds from the offering before deducting underwriting discounts and commissions and offering expenses were approximately $2.8 million.
Maxim Group LLC acted as sole book-running manager for the offering.
The public offering was made pursuant to an effective shelf registration statement on Form S-3, previously filed with the U.S. Securities and Exchange Commission on April 5, 2022 and declared effective on April 21, 2022. The shares of common stock were offered only by means of a prospectus and prospectus supplement that form part of the effective registration statement. A final prospectus supplement describing the terms of the public offering has been filed with the SEC and is available on the SEC's website located at www.sec.gov.
Price Action
cbdMD shares were trading 5.18% higher at $2.03 during Thursday’s pre-market session.
Photo: Benzinga edit with photo by Kindel Media on Pexels
Related News
cbdMD Expands Its Reach To The United Kingdom With Launch On Amazon UK
Wellness Company Milestone: First CBD Brand To Attain Three NSF Certifications For Sports
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Click on the image for more info.
Cannabis rescheduling seems to be right around the corner
Want to understand what this means for the future of the industry?
Hear directly for top executives, investors and policymakers at the Benzinga Cannabis Capital Conference, coming to Chicago this Oct. 8-9.
Get your tickets now before prices surge by following this link.